AKT2 抗体
Quick Overview for AKT2 抗体 (ABIN2715849)
抗原
See all AKT2 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    - 
                                            纯化方法
- Purified from mouse ascites fluids by affinity chromatography
- 
                                            免疫原
- Full length human recombinant protein of human AKT2 (NP_001617) produced in HEK293T cell.
- 
                                            亚型
- IgG2a
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- WB 1:1000, FLOW 1:100,
- 
                                            说明
- 
                        The concentration of the product may vary between diferrent lots. 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- 0.5-1.0 mg/mL
- 
                                            缓冲液
- PBS ( pH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 
- 
                                            
- 
    - AKT2 (V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))
- 
                                            别名
- AKT2
- 
                                            分子量
- 55.6 kDa
- 
                                            基因ID
- 208
- 
                                            NCBI登录号
- NM_001626
- 
                                            HGNC
- 208
- 
                                            途径
- PI3K-Akt Signaling, RTK signaling, AMPK Signaling, TLR signaling, Cellular Glucan Metabolic Process, Regulation of Carbohydrate Metabolic Process, Hepatitis C, VEGF Signaling
 抗原
- 
                    
 
                                     
                                     
                                    